Home/Pipeline/CAR-T/CD19 with TriTE construct

CAR-T/CD19 with TriTE construct

Hematological Cancers

Phase 1Active

Key Facts

Indication
Hematological Cancers
Phase
Phase 1
Status
Active
Company

About Beike Bio-Technology

China's leading adult stem cell therapy company developing novel cell therapies and immunotherapies for oncology and regenerative medicine applications.

View full company profile

Therapeutic Areas

Other Hematological Cancers Drugs

DrugCompanyPhase
BexmarilimabFaron PharmaceuticalsPhase I/II
CTM-PNKCytoMed TherapeuticsPreclinical